SELL and irritable bowel syndrome: We found that IBS patients had evidence of immune activation with an increased percentage of CD4+ T-cells expressing the gut homing marker integrin β7 and the lymph node homing marker CD62L, while CD4+ T-cell derived TNFα was increased in patients with IBS-D when compared to HV.